JED LATKIN

Corporate Board Profile

Tech Score: 0/100

WINDTREE THERAPEUTICS INC /DE/

Filing Date	Source Excerpt
2024-09-03	Jed Latkin has served as a member of our Board since August 2024. Mr. Latkin has served as the Chief Operating Officer and Head of Finance of ProPhase Labs, Inc., or ProPhase, a biotech, genomics and diagnostics company, since January 2023. In his capacity as Chief Operating Officer, Mr. Latkin also serves as ProPhase27s principal financial officer and principal accounting officer. Mr. Latkin served as a director and Chief Executive Officer of Navidea Biopharmaceuticals, Inc., or Navidea, a biopharmaceutical company, from October 2018 until October 2021. Mr. Latkin has more than twenty eight years of experience in the financial industry supporting many investments in major markets, including biotechnology and pharmaceuticals. Mr. Latkin earned a B.A. in Political Science and History from Rutgers University and a M.B.A. in Finance from Columbia Business School.
2025-01-08	/s/ Jed Latkin Jed Latkin President and Chief Executive Officer Windtree Therapeutics, Inc.

Filing Date

Source Excerpt

2024-09-03

Jed Latkin has served as a member of our Board since August 2024. Mr. Latkin has served as the Chief Operating Officer and Head of Finance of ProPhase Labs, Inc., or ProPhase, a biotech, genomics and diagnostics company, since January 2023. In his capacity as Chief Operating Officer, Mr. Latkin also serves as ProPhase27s principal financial officer and principal accounting officer. Mr. Latkin served as a director and Chief Executive Officer of Navidea Biopharmaceuticals, Inc., or Navidea, a biopharmaceutical company, from October 2018 until October 2021. Mr. Latkin has more than twenty eight years of experience in the financial industry supporting many investments in major markets, including biotechnology and pharmaceuticals. Mr. Latkin earned a B.A. in Political Science and History from Rutgers University and a M.B.A. in Finance from Columbia Business School.

2025-01-08

/s/ Jed Latkin Jed Latkin President and Chief Executive Officer Windtree Therapeutics, Inc.

Data sourced from SEC filings. Last updated: 2026-02-03